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AbstrAct
Aims To investigate the relationship between exercise 
participation, exercise ‘dose’ expressed as metabolic 
equivalent (MET) hours (h) per week, and prognosis in 
individuals attending an extended, community-based 
exercise rehabilitation programme.
Methods Cohort study of 435 participants undertaking 
exercise-based cardiac rehabilitation (CR) in Leeds, West 
Yorkshire, UK between 1994 and 2006, followed up to 1 
November 2013. MET intensity of supervised exercise was 
estimated utilising serial submaximal exercise test results 
and corresponding exercise prescriptions. Programme 
participation was routinely monitored. Cox regression 
analysis including time-varying and propensity score 
adjustment was applied to identify predictors of long-term, 
all-cause mortality across exercise dose and programme 
duration groups.
Results There were 133 events (31%) during a median 
follow-up of 14 years (range, 1.2 to 18.9 years). The 
significant univariate association between exercise 
dose and all-cause mortality was attenuated following 
multivariable adjustment for other predictors, including 
duration in the programme. Longer-term adherence to 
supervised exercise training (>36 months) was associated 
with a 33% lower mortality risk (multivariate-adjusted 
HR: 0.67; 95% CI: 0.47 to 0.97; p=0.033) compared with 
all lesser durations of CR (3, 12, 36 months), even after 
adjustment for baseline fitness, comorbidities and survivor 
bias.
Conclusion Exercise dose (MET-h per week) appears 
less important than long-term adherence to supervised 
exercise for the reduction of long-term mortality risk. 
Extended, supervised CR programmes within the 
community may play a key role in promoting long-term 
exercise maintenance and other secondary prevention 
therapies for survival benefit.
IntroductIon
Cardiac rehabilitation (CR) has been shown 
to reduce recurrent cardiovascular disease 
(CVD) and all-cause mortality in individuals 
with coronary heart disease (CHD), inde-
pendently of other risk factors. Two landmark 
observational studies using large, adminis-
trative databases demonstrated a significant 
association between the cumulative number 
of CR sessions attended and this mortality 
risk reduction,1 2 and applied multiple analyt-
ical techniques to limit confounding. These 
studies reported ‘dose-response’ benefits 
of CR from both dichotomous and contin-
uous measures, however, the strength of this 
suggested dose-response association has not 
been replicated across subsequent cohort 
studies.3–5
Stratified analyses of higher versus lower 
exercise doses in consecutive meta-analyses 
of CR have shown no significant association 
with all-cause mortality.6 7 Yet, the composite 
measure of exercise dose used in these anal-
yses comprised only frequency and duration 
of CR exercise and did not include an inte-
gral component of exercise dose; exercise 
intensity. Intensity is a reliable predictor of 
cardiorespiratory fitness gain,8a strong prog-
nostic indicator in patients with CHD.9–11 
Furthermore, trials included in meta-analyses 
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were limited to both short duration exercise interven-
tions (typically 12 to 18 weeks and up to 36 sessions) and 
survival follow-up (median 12 months).7
It is apparent that existing clinical trial or observa-
tional epidemiological evidence has not fully explored 
the role of exercise dose and its integral components 
(exercise intensity, frequency and duration) as a mech-
anism for reduced all-cause mortality risk in patients 
undertaking structured, supervised exercise-based CR. 
No known UK-based CR study has reported on this 
relationship. Recent studies emphasise the need to 
examine this dose-response relationship12 and to rectify 
CR programme deficiencies with alternative secondary 
prevention models. Accordingly, the aim of this study was 
to examine exercise dose and prognosis in a representa-
tive CHD cohort undertaking long-term, supervised CR 
within the community.
methods
study population
This is a cohort study of participants entering a communi-
ty-based CR exercise programme, ‘Heart Watch’ delivered 
by local council leisure services in Leeds, UK, between 
3 January 1994 and 16 October 2006. Participants were 
enrolled with a clinical diagnosis of CHD, were clinically 
stable and discharged from hospital for a minimum of 12 
weeks. Study ethical approval was obtained from Leeds 
East Local Research Ethics Committee (study reference: 
13YH0099) and permission to access data from medical 
records without consent granted by the Health Research 
Authority Confidentiality Advisory Group (study ref: 
CAG5-03[PR6]2013). The primary outcome measure was 
all-cause mortality at 14 years. Survival status was deter-
mined from clinical databases (Leeds Teaching Hospitals’ 
NHS Trust) using full name, date of birth and postcode 
to provide data linkage with the Heart Watch registry.
description of cr programme
The exercise training component of the Heart Watch CR 
programme has been fully described elsewhere.10 It is an 
ongoing maintenance programme centred on supervised 
exercise training in a community setting up to 5 days per 
week. Briefly, participants received mixed circuit-based 
exercise of 24 min with appropriate warm up and cool 
down. On the basis of resting heart rate (HR), final HR 
and rating of perceived exertion (RPE) from baseline and 
consecutive exercise tests, participants were prescribed 
individualised target HR exercise training (up to 85% of 
age-predicted maximum HR).
Assessment of test variables
Indices of submaximal cardiorespiratory fitness (sCRF) 
were obtained from submaximal exercise testing at 
programme entry and subsequent re-tests (initial re-test at 
12 weeks and annually, thereafter). The majority of exer-
cise tests were conducted using a progressive incremental 
treadmill walking protocol designed for use in patients 
with lower levels of functional capacity.13 Participants 
exercised up to a pre-specified test termination criteria 
(in the region of 85% age-predicted maximal HR or RPE 
16, unless clinically contraindicated.14 Directly-deter-
mined VO2 and HR values for corresponding stages of 
this protocol on the treadmill and cycle ergometer have 
been shown to be well-correlated (r=0.94 and r=0.89, 
respectively), indicating comparability between modali-
ties for the small number of participants tested on a cycle 
ergometer.13 Handrail support during treadmill testing 
was discouraged. Participants’ medication status and test 
modality were consistent between exercise tests.
CR workload was described in estimated metabolic 
equivalents (MET; where 1 MET ~3.5 mL O2/kg/min). 
Estimated METs were calculated from the oxygen 
consumption requirements of the final workload during 
sequential submaximal exercise tests using established 
equations,15 16 which corresponded with prescribed exer-
cise (upper training range ~75% HRR). Mean estimated 
MET intensity of CR exercise training was multiplied by 
mean weekly duration (hours) and mean frequency of 
supervised exercise to produce an estimate of MET hours 
[h] per week (ie, mean MET intensity x mean session 
duration [h] x mean weekly frequency). As there are no 
established thresholds for presenting MET-h, median 
values are presented with participants divided into lower 
and higher exercise dose groups (≤6.6 MET-h per week 
and >6.6 MET-h per week, respectively), congruent with 
previous literature.
The cutpoints used to define programme duration 
were 3, 12 and 36 months, reflecting typically reported 
CR durations and a longer-term (>36 months) interven-
tion exceeding most existing RCT evidence.7 Cutpoints 
for baseline sCRF categories (low, moderate, higher) 
were derived from sex-specific distributions of exer-
cise test time congruent with previous literature.11 17 
Comorbid status was assessed using a modified Charlson 
comorbidity score.18 Baseline test date was used to adjust 
for temporal trends in CHD management. Adherence to 
supervised exercise and habitual physical activity were 
obtained from attendance registers and self-reported by 
participants during interview at each re-test. Self-reported 
physical activity and inactivity codes were congruent 
with those applied in the British Regional Heart Study.19 
Activity codes were therefore a relative measure of phys-
ical activity, not a measure of the total time spent in 
activity.
statistical analysis
Measures of central tendency and dispersion are reported 
as mean and SD unless specified and discrete data as 
counts and percentages. The Independent samples t-test 
or Mann-Whitney U test (continuous data) and Fishers 
Exact test (categorical data) were used for comparisons 
between groups, as appropriate.
A propensity score was derived from binary logistic 
regression analysis, using exercise dose as the outcome 
to determine the probability that a participant would 
undergo an above median dose (>6.6 MET-h per week) 
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of supervised exercise training. This propensity score was 
used to adjust for selection bias attributable to non-ran-
domised assignment of exercise dose and baseline 
variables included are provided in supplementary online 
material (see online supplementary table 1). Backward 
stepwise elimination was employed and resultant inde-
pendent predictors used to calculate propensity score.
A parsimonious Cox proportional-hazards (backward 
stepwise) model was used to assess the effect of variables 
on survival. Proportionality of hazards were tested using 
a log(-log(survival)) plot versus log(time) plot and partial 
residuals. Multicollinearity was assessed using variance 
inflation factors. Prognostic factors statistically signifi-
cant at the 5% level in univariate analyses were entered 
into multivariable Cox models. Extended Cox regression 
models were constructed to account for non-proportion-
ality in conventional models. The time axis was partitioned 
at the point where a distinct change in the slope of the 
hazard was observed (at 9 years) and hazard ratios were 
then estimated for each time interval independently.20 
Multivariate Cox regression models were adjusted for 
confounders, significant univariate predictors of all-cause 
death and individual propensity scores. To account for 
time-dependent ‘survivor’ bias21 programme duration 
was also analysed as a time-dependent covariate. Kaplan–
Meier analysis (log-rank test) was applied to verify the 
time-dependent occurrence of death in groups strati-
fied by exercise dose. A mixed model two-way ANOVA 
was used to assess changes in sCRF indices across groups. 
For variables of primary interest data were complete and 
missing data in other variables accounted for <5% of the 
final sample. SPSS 23.0 (IBM SPSS, USA) was used for all 
analyses.
results
Participant characteristics
A total of 994 participants were enrolled to CR. Those 
who died within 12 months of their baseline assessment 
(n=7); without complete follow-up (n=315); or without 
a valid baseline exercise test (n=2) were excluded from 
the analysis of cohort characteristics at baseline (n=670). 
Follow-up was complete to 1 November 2013. Two-hun-
dred and three participants (30%) in the CR cohort did 
not return for initial CR re-assessment scheduled at 12 
weeks however were similar to completers with respect to 
survival over 14 years (age-adjusted HR: 1.10; 95% CI: 0.82 
to 1.48; log rank p=0.520 for non-completers compared 
with completers). For the assessment of CR exercise 
dose, non-completers (n=203) and participants without 
a valid measure of weekly exercise training frequency 
(n=32) were excluded, leaving a final study population of 
n=435. Baseline participant characteristics are displayed 
in supplementary material online, see online supplemen-
tary table S2 and S3.
Participants undertaking a lower volume of supervised 
exercise underwent a median 4.9 MET-h per week (inter-
quartile range [IQR] 3.3 to 5.6 MET-h) during 30 months 
of CR (IQR 3 to 85 months). Those undertaking a higher 
volume underwent a median 8.4 MET-h per week (IQR 
7.3 to 10.0 MET-h; p<0.0005) during 42 months of CR 
(IQR 3 to 100 months; p=0.070). The frequency of super-
vised exercise for lower and higher exercise dose groups 
was 2 (IQR 1 to 2) sessions per week and 3 (IQR 2 to 3) 
sessions per week (p<0.0005), respectively. Those under-
taking a lower volume of supervised exercise were older, 
more likely to be female, less physically active, had lower 
sCRF levels (estimated METs) and attained a higher % of 
age-predicted maximum exercise HR on baseline testing. 
They were also more likely to be using diuretic therapy 
and less likely to have a prescription for antiplatelet 
therapy. Median propensity scores were consistent with 
differences in baseline characteristics between exercise 
dose groups: 0.54 (IQR: 0.40 to 0.69) and 0.63 ([IQR: 
0.55 to 0.73]; p<0.0005), respectively.
Thirty-one per cent of the entire cohort died (n=133) 
during a median follow-up of 14 years (range, 1.2 to 
18.9 years). Significant univariate predictors of all-cause 
mortality were: age, baseline sCRF, duration in the 
programme, modified Charlson comorbidity index score, 
taking specific cardioprotective medication (diuretic, 
statin, ACE-inhibitor, calcium channel blocker and anti-
platelet therapies), diabetes, TC/HDL-c ratio, date of 
CR programme entry and employment status. Exercise 
dose (MET-h per week) treated as a continuous variable 
was inversely associated with all-cause mortality (HR 
0.94; 95% CI 0.89 to 1.00; p=0.05). Sex, smoking status, 
previous MI, β-blocker use, digoxin use, hypertension, 
BMI, self-reported physical inactivity, family history, 
indices of multiple social deprivation and test modality 
were not significant univariate predictors in this cohort.
MET-h of supervised CR exercise was associated with 
an unadjusted HR of 0.70 (95% CI, 0.50 to 0.98; p=0.038) 
and significantly lower all-cause mortality on Kaplan-
Meier analysis (figure 1) (online supplementary figure 
S1compares CR completers stratified by exercise dose 
with non-completers). With evidence of late separation 
of event curves and non-constant risk during follow-up 
(confirmed in log-minus-log plots), early and late 
follow-up periods were analysed independently. Ttable 1 
displays results from the extended multivariate Cox 
regression models.
Following multivariable adjustment for confounding 
variables and propensity score, the strongest prognostic 
factors for all-cause mortality were: duration in the CR 
programme, age, baseline sCRF and secondary preven-
tion medication use (ACE inhibitor, calcium channel 
blocker, statin and diuretic), respectively. The univariate 
association between exercise dose and mortality was not 
found to be independent of these factors (propensity 
score-adjusted HR: 1.14; 95% CI: 0.74 to 1.76).
Multivariable model 1: adjusted for significant univar-
iate predictors (age, sCRF, diuretic, statin, ACE-inhibitor, 
calcium channel blocker use, modified Charlson comor-
bidity index, date of first test, duration in CR programme, 
diabetes and employment status.
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Figure 1 Unadjusted Kaplan-Meier plot comparing CR participants dichotomised on the basis of CR exercise dose 
undertaken (MET-h per week).
Table 1 Estimated hazard ratios (95% CI) for all-cause mortality based on supervised exercise dose (MET-h per week) in 
independent Cox models for two time periods
Model Event time <9 years Event time >9 years
HR* 95% CI P Value HR 95% CI P Value
Unadjusted 0.85 0.53 to 1.36 0.492 0.57 0.35 to 0.92 0.023
Multivariate Model 1 1.67 1.00 to 2.88 0.049 1.02 0.60 to 1.73 0.939
Multivariate Model 2 (propensity score) 1.32 0.76 to 2.30 0.322 0.98 0.56 to 1.72 0.949
*HR for exercise volume >6.6 MET-h per week (≤6.6. MET-h per week is reference category) Time partitioning at 9 years corresponds to a 
distinct change in the slope of the hazard.
Multivariable model 2: adjusted for propensity score 
(age, sex, sCRF, ACE-inhibitor, β-Blocker use and BMI) 
and other significant univariate predictors: duration in 
programme, statin, diuretic, calcium channel blocker, 
antiplatelet therapy use, modified Charlson comorbidity 
index, date of first test, diabetes, TC/HDL-c ratio and 
employment status
Undertaking >6.6 MET-h supervised exercise training 
was associated with a lower risk of mortality after >9 years 
follow-up, however risk estimates were attenuated.
There were no statistically significant interactions 
between exercise dose and changes in indices of sCRF. 
All participants completing CR improved their exer-
cise test duration (p<0.0005) between first and final 
re-test: >6.6 MET-h per week (1.5±2.7 min) and ≤6.6 MET-h 
per week (1.3±2.3 min). Similarly, there were no clinically 
meaningful differences between groups with respect to 
change in resting or peak HR.
Given the strong prognostic influence of long-term 
programme adherence in this cohort, stratified analysis 
by programme adherence (up to 3, 12 and 36 months 
and >36 months supervised exercise) was also performed. 
figure 2 illustrates the cumulative event rates for these 
short-term, extended and long-term CR groups.
Undertaking more than 36 months supervised exer-
cise was associated with a 51% lower risk of death from 
all causes over 14 years (multivariate-adjusted HR: 0.49; 
95% CI: 0.34 to 0.72; p<0.0005), compared with all other 
durations of CR: 48% lower compared with participants 
adhering up to 36 months (multivariate-adjusted HR: 
0.52; 95% CI: 0.31 to 0.87; p=0.013); and 60% lower 
compared with those adhering up to 12 months (multi-
variate-adjusted HR: 0.40; 95% CI: 0.23 to 0.69; p=0.001). 
The risk estimate compared with participants under-
taking short-term CR (up to 3 months) and accounting 
for non-proportional hazards during follow-up was 
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Figure 2 Unadjusted Kaplan-Meier plot comparing CR participants stratified by duration in the programme (3,12 and 
36 month cutpoints).
Table 2 Estimated hazard ratios (95% CI) for all-cause mortality based on long-term (>36 months) supervised CR exercise in 
time-dependent Cox regression analysis
Model
Long-term (>36 months) adherence to CR
HR* 95% CI P Value
Unadjusted 0.64 0.45 to 0.92 0.015
Age-adjusted 0.60 0.42 to 0.87 0.006
Multivariable Model 0.67 0.47 to 0.97 0.033
*HR for >36 months CR (≤36 months is reference). Multivariable model adjusted for: age, baseline sCRF, modified Charlson comorbidity 
index and secondary prevention medications (diuretic and ACE-inhibitor).
Coronary artery disease
29% (multivariate-adjusted HR: >3 years follow-up: 
0.71; 95% CI: 0.45 to 1.12; p=0.142). To further account 
for survivor selection bias among those attending >36 
months of CR, Cox regression analysis was repeated 
with long-term programme duration as a time-depen-
dent covariate. Following multivariate adjustment for 
the strongest predictors of all-cause mortality, long-term 
adherence to supervised CR exercise remained predic-
tive of mortality risk reduction (table 2).
dIscussIon
This study evaluated the impact of exercise ‘dose’ (volume 
expressed as MET-h per week) in a CR cohort undergoing 
long-term, exercise-based rehabilitation. Consistent with 
previous observational studies3 4 and recent meta-anal-
ysis,7 we found that a higher dose of exercise training was 
not associated with a significantly lower risk of all-cause 
mortality. Other prognostic factors, namely, cardiorespi-
ratory fitness level at entry and extended CR programme 
adherence were more important predictors of mortality 
over 14 years. Though, importantly, exercise dose 
groups did not differ significantly with respect to overall 
programme adherence. A key finding was that longer-
term (>36 months) supervised CR exercise was associated 
with a significant stepwise survival benefit compared 
with all lesser durations. The findings herein therefore 
support the case for supervised, open-ended exercise 
training programmes within the community setting for 
long-term survival benefit.
In contrast to other large retrospective analyses of 
healthcare databases1 2 we did not find an independent 
protective effect of exercise dose in the long-term. In 
older propensity-matched patients, Suaya and colleagues2 
found a significant difference in the cumulative mortality 
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rates of low (1 to 24 sessions) and high (25+ sessions) 
CR users after 5 years.2 Similarly, among older Medicare 
beneficiaries, Hammill and co-investigators1 observed 
that patients who participated in 36 sessions (maximum 
available) had a significantly lower risk of death at 4 
years than those who attended fewer sessions.1 Potential 
explanations for such disparities between cohorts are 
likely to be due to length patient follow-up, minimum 
CR attendance requirements, age and overall burden of 
comorbidities in earlier cohorts.
Not all studies have demonstrated a beneficial effect 
of CR exercise dose on mortality4 and our results are 
consistent with other observations reporting longer-
term follow-up.3 5 In ~5000 propensity-matched patients 
referred to the Cardiac Wellness Institute, Calgary, Canada 
for 12 weeks CR, Martin and co-investigators (2013) 
demonstrated that each additional CR session attended 
was associated with a 1% decrease in mortality (unad-
justed HR 0.99 95% CI 0.98 to 0.99) over 5 years4. This 
association was lost when restricting analysis to patients 
completing a minimum of 12 weeks CR. Over comparable 
long-term follow-up to the present study, Beauchamp and 
co-investigators (2013) reported that attending <25% of 
available CR sessions of low-moderate intensity exercise 
over six to eight sessions was associated with a mortality 
risk twice that of patients attending >75% of sessions, 
though this association was lost following adjustment for 
smoking status.
Overall, it appears that existing data do not support a 
clear or consistent strength of dose-response relationship 
between supervised CR exercise and all-cause mortality 
risk. Indeed, the heterogeneous character of programmes 
and absence of reported exercise prescriptions impedes 
its interpretation. Although a recent comprehensive 
review of high-quality RCT evidence recently found no 
significant reduction in all-cause mortality (relative risk: 
1.01; 95% CI 0.89 to 1.15) with a higher dose of exer-
cise-based CR,7 the short-term follow-up (median 12 
months) and the quantification of dose by only duration 
and frequency, is likely to be inherently limited for the 
evaluation of this relationship. To the best of our knowl-
edge, our study is the first to examine the effect of an 
extended length, exercise-rehabilitation programme 
(>36 months) on long-term mortality outcomes. Early 
trial findings from the National Exercise and Heart 
Disease Project, reported reductions in all-cause mortality 
ranging from 8% to 14% per 1-MET increment in CRF 
following 6 months supervised exercise training.22
Our finding that short-term (up to 3 months) and long-
term CR adherers (>36 months) did not appear to differ 
with respect to all-cause mortality risk may be explained in 
part, by sociodemographic factors. Short-term adherers 
were younger and had the highest percentage of working 
age participants in the cohort overall (53%). Working 
status has been shown to be an important participation 
barrier to CR,23 which may support the contention that 
these participants left CR earlier to follow their own exer-
cise training or habitual physical activity programme.24 
Another noteworthy finding from the present cohort 
was that half of all participants undertaking a lower 
dose of exercise during CR were among the lowest fit 
at programme entry and undertook, on average, one 
fewer CR exercise session per week compared with those 
undertaking a higher dose. This suggests a ‘self-selection’ 
of a lower exercise dose by participants at the lower end 
of the fitness distribution. We have recently reported10 
a 27% relative risk reduction in all-cause mortality per 
1-MET gain achieved during CR for those with low fitness 
levels. Therefore, if the long-term secondary preventative 
benefits of exercise rehabilitation are to be attained then 
continued exercise supervision of lower fit individuals 
within extended community-based programmes may be 
beneficial.
Strengths of the present study include the length of 
complete follow-up for all-cause mortality including 
CR non-completers, detailed information on covariates 
(including smoking history and secondary prevention 
medications), extended multivariate Cox regression 
modelling including time-varying covariates, and the 
quantification of frequency, duration and intensity for 
the assessment of exercise dose.
limitations
Although we have attempted to address the most 
common biases it is possible that the association 
between CR programme duration and mortality may 
be confounded by unmeasured or other ‘healthy-adh-
erer’ behaviours.25 Given the importance of CRF on the 
prognosis of patients with CHD17 it is a limitation that 
fitness measures were not available for all patients after 
they left the programme. Though we included covariate 
adjustment for propensity score in our Cox regression 
models, the propensity score matching methodology has 
been suggested to provide the most precise estimate of 
‘treatment’ effect. However, matching does not perform 
well when the number of ‘treated’ subjects is larger than 
the number of ‘untreated’ subjects,26 as was the case in 
our cohort. The lower dose of CR exercise associated 
with cycle ergometer testing may indicate an influence 
of test modality27 on long-term outcomes however, exer-
cise mode was not a significant univariate predictor of 
mortality in the cohort overall.
The inability to report actual training heart rates from 
supervised CR exercise to quantify exercise dose is a 
limitation common to large observational cohorts, but 
may explain the lack of observed association between 
exercise dose and all-cause mortality risk in this study. 
Further dose-response analyses in large well-controlled 
studies of supervised exercise training over medium and 
long-term follow-up are therefore required to quantify 
any dose-related improvements in clinical outcomes. 
Future studies should aim to capture an overall measure 
of exercise dose (including exercise intensity, frequency 
and duration components), or corresponding cardiore-
spiratory fitness level, which could serve as the basis of a 
minimal dose recommendation for clinical benefit.
group.bmj.com on August 3, 2017 - Published by http://openheart.bmj.com/Downloaded from 
7Taylor C, et al. Open Heart 2017;4:e000623. doi:10.1136/openhrt-2017-000623
Coronary artery disease
Finally, it is noted that our finding that certain cardi-
oprotective medications, notably ACE-inhibitor and 
diuretic therapies were independent adverse predictors 
of all-cause mortality is contrary to strong RCT evidence.28 
Findings may reflect differences in underlying disease 
severity, prevalence of co-morbidities and self-selection of 
low volume exercise training.
conclusIon
The results of this study suggest that long-term supervised 
exercise rehabilitation (>36 months) is associated with a 
markedly lower risk of all-cause mortality and supports 
the benefits of continued exercise supervision within 
community-based CR programmes.
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